GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taiko Pharmaceutical Co Ltd (TSE:4574) » Definitions » ROE % Adjusted to Book Value

Taiko Pharmaceutical Co (TSE:4574) ROE % Adjusted to Book Value : 5.82% (As of Jun. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Taiko Pharmaceutical Co ROE % Adjusted to Book Value?

Taiko Pharmaceutical Co's ROE % for the quarter that ended in Jun. 2024 was 15.07%. Taiko Pharmaceutical Co's PB Ratio for the quarter that ended in Jun. 2024 was 2.59. Taiko Pharmaceutical Co's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was 5.82%.


Taiko Pharmaceutical Co ROE % Adjusted to Book Value Historical Data

The historical data trend for Taiko Pharmaceutical Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiko Pharmaceutical Co ROE % Adjusted to Book Value Chart

Taiko Pharmaceutical Co Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Dec21 Dec22
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.91 5.42 3.86 -21.30 -22.05

Taiko Pharmaceutical Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.15 -1.13 -65.71 10.18 5.82

Competitive Comparison of Taiko Pharmaceutical Co's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Taiko Pharmaceutical Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taiko Pharmaceutical Co's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Taiko Pharmaceutical Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Taiko Pharmaceutical Co's ROE % Adjusted to Book Value falls into.



Taiko Pharmaceutical Co ROE % Adjusted to Book Value Calculation

Taiko Pharmaceutical Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-46.96% / 2.13
=-22.05%

Taiko Pharmaceutical Co's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=15.07% / 2.59
=5.82%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Taiko Pharmaceutical Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Taiko Pharmaceutical Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Taiko Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 34 Third Street, No. 14, Uchihon Suita, Osaka, JPN, 564-0032
Taiko Pharmaceutical Co Ltd operates in three segments, namely Pharmaceutical, Infection Control, and Others. The majority of its revenue comes from Infection Control, which is into manufacturing and sales of sanitation control products, including Cleverin, Cleverin LED, and Cleverin Generator LISPASS. The pharmaceutical segment is into the manufacturing and sales of OTC medicines and designated quasi-drugs. Other business includes manufacturing and sales of wood vinegar-based products.

Taiko Pharmaceutical Co Headlines

No Headlines